Available for licensing from NIH: BOG gene and protein product for Rx, Dx use Feb. 15, 1999 No Comments
Aronex initiates phase I/II trial of Atragen + interferon alfa in renal cell carcinoma Feb. 15, 1999 No Comments
Positive preclinical results for NuChem's anticancer compounds in lung cancer model Feb. 12, 1999 No Comments